Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Computable Name: | ||||
version: 71; Last updated: 2026-08-06 19:22:47+0000
ArtifactPublicationStatus: Active
url: https://fevir.net/resources/EvidenceVariable/236965
identifier: FEvIR Object Identifier/236965, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-313960, outcomeId/313960, picoId/85798, sectionId/73215
name: End_stage_kidney_disease313960
title: OutcomeDefinition for End-stage kidney disease
shortTitle: End-stage kidney disease
citeAs:
OutcomeDefinition for End-stage kidney disease [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236965. Revised 2026-08-06. Available at: https://fevir.net/resources/EvidenceVariable/236965. Computable resource at: https://fevir.net/resources/EvidenceVariable/236965#json.
status: Active
author: Computable Publishing®: MAGIC-to-FEvIR Converter:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description:
End-stage kidney disease
copyright:
Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
| Type | Target[x] |
| Part Of | MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report) |
| Concept |
| End-stage kidney disease |
handling: dichotomous variable